A multidisciplinary guideline panel convened by the American Association of Bronchology and Interventional Pulmonology (AABIP ...

Balloon pulmonary angioplasty led to clinical improvements and relatively low complication rates for CTEPH patients in a ...

Lung function tests (or pulmonary function tests) include a variety of tests that check how well the lungs work.

The National Institutes of Health announced plans to limit publisher fees for publicly funded research by Fiscal Year 2026.

Dupilumab reduces COPD exacerbations and Type 2 inflammation biomarkers, with strongest benefit in patients with high ...

This new article publication from Acta Pharmaceutica Sinica B, discusses how SRSF7 promotes pulmonary fibrosis through regulating PKM alternative splicing in lung fibroblasts.

The correspondence of Joan B Soriano and Alberto Ruano-Ravina deserves timely praise, highlighting the threat that predatory ...

The CAAT governance board recommends transitioning from the COPD Assessment Test to the CAAT and using it for patients with ...

There is increased risk for pulmonary hypertension in patients with both atrial fibrillation and incident venous thromboembolism.

The pulmonary arterial hypertension market is expected to reach USD 2,080.7 million by 2025 and is expected to steadily grow at a CAGR of 2.3% to reach USD 2,612.0 million by 2035.

This guideline is based on a comprehensive review of the literature on pulmonary nodules and expert opinion. Although the management pathway for the majority of nodules detected is straightforward it ...

Pulmonary hypertension (PH) is a progressive disease with a poor prognosis. Identifying chronic thromboembolic pulmonary disease as a cause of PH has major clinical implications as these patients ...